# BlackRock, Inc.: financial statements, quarterly

BLK · NYSE · CIK 2012383 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/blk.md) · [Financials](/companies/blk/financials.md) · [Filings](/companies/blk/filings.md) · [Insiders](/companies/blk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/blk/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,522](/filings/0000950170-24-122256.md) | [4,631 d](/filings/0001193125-26-071966.md) | [4,728](/filings/0000950170-25-065838.md) | [4,805](/filings/0000950170-25-103780.md) | [5,197](/filings/0001193125-25-267043.md) | [5,677 d](/filings/0001193125-26-071966.md) | [5,276](/filings/0001193125-26-208766.md) | [5,423](/filings/0001193125-26-337177.md) | [6,509](/filings/0001193125-25-267043.md) | [7,008 d](/filings/0001193125-26-071966.md) | [6,698](/filings/0001193125-26-208766.md) | [7,084](/filings/0001193125-26-337177.md) |
| Operating income | $m | [1,637](/filings/0000950170-24-122256.md) | [1,585 d](/filings/0001193125-26-071966.md) | [1,693](/filings/0000950170-25-065838.md) | [1,800](/filings/0000950170-25-103780.md) | [2,006](/filings/0001193125-25-267043.md) | [2,075 d](/filings/0001193125-26-071966.md) | [1,698](/filings/0001193125-26-208766.md) | [1,731](/filings/0001193125-26-337177.md) | [1,955](/filings/0001193125-25-267043.md) | [1,661 d](/filings/0001193125-26-071966.md) | [2,814](/filings/0001193125-26-208766.md) | [2,461](/filings/0001193125-26-337177.md) |
| Interest expense | $m | [82.0](/filings/0000950170-24-122256.md) | [82.0 d](/filings/0001193125-26-071966.md) | [92.0](/filings/0000950170-25-065838.md) | [126](/filings/0000950170-25-103780.md) | [154](/filings/0001193125-25-267043.md) | [166 d](/filings/0001193125-26-071966.md) | [166](/filings/0001193125-26-208766.md) | [173](/filings/0001193125-26-337177.md) | [135](/filings/0001193125-25-267043.md) | [140 d](/filings/0001193125-26-071966.md) | [134](/filings/0001193125-26-208766.md) | [134](/filings/0001193125-26-337177.md) |
| Income tax | $m | [213](/filings/0000950170-24-122256.md) | [438 d](/filings/0001193125-26-071966.md) | [290](/filings/0000950170-25-065838.md) | [477](/filings/0000950170-25-103780.md) | [574](/filings/0001193125-25-267043.md) | [442 d](/filings/0001193125-26-071966.md) | [248](/filings/0001193125-26-208766.md) | [587](/filings/0001193125-26-337177.md) | [470](/filings/0001193125-25-267043.md) | [372 d](/filings/0001193125-26-071966.md) | [516](/filings/0001193125-26-208766.md) | [677](/filings/0001193125-26-337177.md) |
| Net income | $m | [1,604](/filings/0000950170-24-122256.md) | [1,375 d](/filings/0001193125-26-071966.md) | [1,573](/filings/0000950170-25-065838.md) | [1,495](/filings/0000950170-25-103780.md) | [1,631](/filings/0001193125-25-267043.md) | [1,670 d](/filings/0001193125-26-071966.md) | [1,510](/filings/0001193125-26-208766.md) | [1,593](/filings/0001193125-26-337177.md) | [1,323](/filings/0001193125-25-267043.md) | [1,127 d](/filings/0001193125-26-071966.md) | [2,212](/filings/0001193125-26-208766.md) | [1,914](/filings/0001193125-26-337177.md) |
| Diluted EPS | $ per share | [10.66](/filings/0000950170-24-122256.md) | not reported | [10.48](/filings/0000950170-25-065838.md) | [9.99](/filings/0000950170-25-103780.md) | [10.90](/filings/0001193125-25-267043.md) | not reported | [9.64](/filings/0001193125-26-208766.md) | [10.19](/filings/0001193125-26-337177.md) | [8.43](/filings/0001193125-25-267043.md) | not reported | [14.06](/filings/0001193125-26-208766.md) | [12.19](/filings/0001193125-26-337177.md) |
| Basic EPS | $ per share | [10.75](/filings/0000950170-24-122256.md) | not reported | [10.58](/filings/0000950170-25-065838.md) | [10.07](/filings/0000950170-25-103780.md) | [11.02](/filings/0001193125-25-267043.md) | not reported | [9.74](/filings/0001193125-26-208766.md) | [10.29](/filings/0001193125-26-337177.md) | [8.54](/filings/0001193125-25-267043.md) | not reported | [14.24](/filings/0001193125-26-208766.md) | [12.34](/filings/0001193125-26-337177.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | [8.7](/filings/0000950170-25-026584.md) | not reported | not reported | [14.0](/filings/0000950170-24-122256.md) | [12.8](/filings/0001193125-26-071966.md) | [7.7](/filings/0000950170-25-065838.md) | [9.5](/filings/0000950170-25-103780.md) | [10.0](/filings/0001193125-25-267043.md) | [11.5](/filings/0001193125-26-337177.md) | [9.8](/filings/0001193125-26-208766.md) | [10.5](/filings/0001193125-26-337177.md) |
| Total assets | $bn | not reported | [123](/filings/0000950170-25-026584.md) | not reported | not reported | [133](/filings/0000950170-24-122256.md) | [139](/filings/0001193125-26-071966.md) | [142](/filings/0000950170-25-065838.md) | [146](/filings/0000950170-25-103780.md) | [163](/filings/0001193125-25-267043.md) | [170](/filings/0001193125-26-337177.md) | [170](/filings/0001193125-26-208766.md) | [176](/filings/0001193125-26-337177.md) |
| Total liabilities | $bn | not reported | [82.0](/filings/0000950170-25-026584.md) | not reported | not reported | [89.2](/filings/0000950170-24-122256.md) | [89.3](/filings/0001193125-26-071966.md) | [91.8](/filings/0000950170-25-065838.md) | [94.9](/filings/0000950170-25-103780.md) | [101](/filings/0001193125-25-267043.md) | [108](/filings/0001193125-26-337177.md) | [107](/filings/0001193125-26-208766.md) | [111](/filings/0001193125-26-337177.md) |
| Long-term debt | $bn | not reported | [7.9](/filings/0000950170-25-026584.md) | not reported | not reported | [12.4](/filings/0000950170-24-122256.md) | [12.3](/filings/0001193125-26-071966.md) | [12.3](/filings/0000950170-25-065838.md) | [12.8](/filings/0000950170-25-103780.md) | [12.8](/filings/0001193125-25-267043.md) | [12.8](/filings/0001193125-26-337177.md) | [12.7](/filings/0001193125-26-208766.md) | [12.7](/filings/0001193125-26-337177.md) |
| Shareholders' equity | $bn | [38.8](/filings/0000950170-24-122256.md) | [39.3](/filings/0000950170-25-026584.md) | [39.9](/filings/0000950170-25-103780.md) | [40.3](/filings/0001193125-25-267043.md) | [41.2](/filings/0000950170-24-122256.md) | [47.5](/filings/0001193125-26-071966.md) | [48.0](/filings/0000950170-25-065838.md) | [49.1](/filings/0000950170-25-103780.md) | [55.5](/filings/0001193125-25-267043.md) | [55.9](/filings/0001193125-26-337177.md) | [56.7](/filings/0001193125-26-208766.md) | [57.6](/filings/0001193125-26-337177.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,998 d](/filings/0001193125-26-071966.md) | [(408)](/filings/0000950170-25-065838.md) | [1,365 d](/filings/0000950170-25-103780.md) | [1,381 d](/filings/0001193125-25-267043.md) | [2,618 d](/filings/0001193125-26-071966.md) | [(1,128)](/filings/0001193125-26-208766.md) | [1,364 d](/filings/0001193125-26-337177.md) | [1,414 d](/filings/0001193125-25-267043.md) | [2,277 d](/filings/0001193125-26-071966.md) | [(980)](/filings/0001193125-26-208766.md) | [1,227 d](/filings/0001193125-26-337177.md) |
| Capital expenditure | $m | [124 d](/filings/0001193125-26-071966.md) | [64.0](/filings/0000950170-25-065838.md) | [7.0 d](/filings/0000950170-25-103780.md) | [94.0 d](/filings/0001193125-25-267043.md) | [90.0 d](/filings/0001193125-26-071966.md) | [78.0](/filings/0001193125-26-208766.md) | [89.0 d](/filings/0001193125-26-337177.md) | [78.0 d](/filings/0001193125-25-267043.md) | [130 d](/filings/0001193125-26-071966.md) | [106](/filings/0001193125-26-208766.md) | [109 d](/filings/0001193125-26-337177.md) |
| Dividends paid | $m | [743 d](/filings/0000950170-25-026584.md) | [795](/filings/0000950170-25-065838.md) | [758 d](/filings/0000950170-25-103780.md) | [757 d](/filings/0000950170-24-122256.md) | [791 d](/filings/0000950170-25-026584.md) | [838](/filings/0000950170-25-065838.md) | [808 d](/filings/0000950170-25-103780.md) | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [384 d](/filings/0000950170-25-026584.md) | [634](/filings/0000950170-25-065838.md) | [519 d](/filings/0000950170-25-103780.md) | [391 d](/filings/0000950170-24-122256.md) | [386 d](/filings/0000950170-25-026584.md) | [657](/filings/0000950170-25-065838.md) | [396 d](/filings/0000950170-25-103780.md) | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [151](/filings/0000950170-24-122256.md) | [150](/filings/0000950170-25-065838.md) | [150](/filings/0000950170-25-103780.md) | [150](/filings/0001193125-25-267043.md) | [157](/filings/0001193125-26-208766.md) | [156](/filings/0001193125-26-337177.md) | [165](/filings/0001193125-25-267043.md) | [165](/filings/0001193125-26-208766.md) | [165](/filings/0001193125-26-337177.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 154,926,181 at 2025-04-30, from the cover of the [10-Q filed 2025-05-07](/filings/0000950170-25-065838.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.